Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.
about
Arterial Therapies of Non-Colorectal Liver MetastasesTranscatheter embolization therapy in liver cancer: an update of clinical evidencesManagement of patients with hepatic metastases from neuroendocrine tumorsIntrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management.Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profileSafety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results.Surgical management of noncolorectal cancer liver metastases.Therapeutic strategies for neuroendocrine liver metastases.Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors.Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.Treatment of neuroendocrine tumor liver metastases.Liver transarterial embolizations in metastatic neuroendocrine tumors.Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis.Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor
P2860
Q26764990-3DAE7EEE-3EBA-4037-BA8B-C0E29C2BFF05Q27003849-8FED4ABC-FCD6-4F64-9A47-C9C636E8235AQ27008832-E382F12E-79C9-4255-A2C5-6C1B2D8ED4C0Q33748348-F79B2182-D4D1-467B-B5E0-D8DDDC602766Q35795014-7C0C5E65-16C2-432A-AD4E-9B5C8351E5E7Q37671474-CB61AE8A-9903-40CD-9F5D-7E51C98437CFQ38224364-013EF11D-6C70-4EBE-8291-86AD074EBFE8Q38255979-8CCD01E4-2671-435A-9EAB-C75C30CE5AF7Q38264620-B0D519F8-58A2-42C0-A7A4-9913D5BEC523Q38581192-DBF571C3-2A28-4978-A2AA-622354809470Q38590448-8265C251-01C0-450C-BAC8-836824386418Q38693622-B35D47CD-1054-4829-84C5-41184671914AQ39349632-A79F056C-BF12-4B16-9D43-B79E0ADEA665Q40542715-85D7A02E-3C8E-4E7B-B6AC-BE141C4B5964Q40642628-A761A3DC-EC66-4C48-B984-72D04C9C9EB0Q41196104-8AA34BAB-8E58-43A3-8976-A9ACAF0507EBQ42287138-67B236E0-433A-4967-803D-26FEA79B1D1BQ47869784-2C58A9CF-2CB3-4298-AC59-B6BD4839CE48Q49762899-09778B33-8C21-40F2-B582-6CC3A1F87E91Q51585612-9CE53A8F-BDF5-4078-AB98-4B7CEFA4B1C7Q57145632-D6DEA0AB-6466-494D-B764-786E53EE895E
P2860
Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@ast
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@en
type
label
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@ast
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@en
prefLabel
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@ast
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@en
P2093
P2860
P1476
Phase II study of chemoemboliz ...... h incidence of biliary injury.
@en
P2093
Constantine Frangakis
Diane K Reyes
Ihab Kamel
J F Geschwind
Mingde Lin
Nikhil Bhagat
P2860
P2888
P304
P356
10.1007/S00270-012-0424-Y
P577
2012-06-22T00:00:00Z